Nan fang yi ke da xue xue bao = Journal of Southern Medical University
January 20, 2026
Ke Xia, Tianming Gao
Depression is a complex and globally prevalent mental disorder, for which conventional antidepressant medications face limitations such as delayed onset and insufficient efficacy. Classic psychedelics, most notably psilocybin, have recently emerged as promising candidates for treatment of depression and demonstrated rapid, robust, and sustained antidepressant effects in controlled clinical...
Annals of Neurosciences
January 19, 2026
Gyaneshwar Singh, Saleema Js, Krishna Dwivedi et al.
Background: Electroencephalography (EEG) studies consistently associate alpha-band oscillations with relaxation, internalized attention, and sensory disengagement during meditation. However, limited evidence exists on how Heartfulness Meditation (HM), particularly its unique transmission phases, modulates alpha activity across different experience levels. Purpose: This study investigated...
Zenodo (CERN European Organization for Nuclear Research)
January 19, 2026
Ngo Cheung
1 citation
preprint
Background: Major depressive disorder involves impaired neural plasticity, yet antidepressants targeting glutamatergic (ketamine), monoaminergic (SSRIs), and GABAergic (neurosteroids) pathways differ markedly in onset speed, durability, and risk of treatment-emergent mania—particularly in bipolar contexts. Clinical comparisons are confounded by heterogeneity; computational models enable...
bioRxiv (Cold Spring Harbor Laboratory)
January 13, 2026
Iván Mindlin, Carlos Coronel-Oliveros, Jacobo Sitt et al.
preprint
A main characteristic of biological systems is their capacity to dynamically adapt to environmental changes. In the brain, synaptic plasticity enables the strengthening or weakening of connections between neurons, allowing neural circuits to adapt based on experience, learning, and environmental changes. Yet, it is homeostatically regulated such that it avoids excessive proliferation of...
Journal of Psychopharmacology
January 6, 2026
Connor J. Maltby, Adam K. Klein, Enya Paschen et al.
3 citations
Background: Psilocybin has shown rapid and sustained antidepressant effects in patients with major depressive disorder, yet the neurobiological mechanisms underlying these outcomes remain unclear. Aims: This study aimed to bridge clinical and preclinical findings by investigating the relationships between 5-HT 2A receptor occupancy (RO) achieved after administration of psilocybin and its...
Frontiers in Psychology
2026
Kaiyu Qiu, Zixiu Jiang, Ke Jiang et al.
Synaesthesia is commonly defined as an involuntary and consistent phenomenon in which stimulation in one sensory or cognitive domain elicits an additional experience in another domain. Yet definitions derived from perceptual psychology, neuroscience, aesthetics, cultural anthropology, and artistic practice often speak past one another. This article proposes a boundary-preserving conceptual...
Frontiers in Cell and Developmental Biology
2026
Lihua Yang, Shuang Wu, Jiale Liu et al.
Drug addiction is a complex, chronic, and relapsing neurological disorder characterized by persistent neuroadaptation and a substantial public health burden. Because of its simple nervous system, genetic tractability, short life cycle, transparent body, and quantifiable behavioral phenotypes, C. elegans (Caenorhabditis elegans) has become a useful complementary model for studying selected...
Neuroscience of Consciousness
2026
Vikas O'Reilly-Shah, Alessandro Maria Selvitella, Aaron Schurger
The unfolding argument in the neuroscience of consciousness posits that causal structure cannot account for consciousness because any recurrent neural network (RNN) can be "unfolded" into a functionally equivalent feedforward neural network (FNN) with identical input-output behavior. Subsequent debate has focused on dynamical properties and philosophy of science critiques. We examine a boundary...
SSRN Electronic Journal
2026
Dennis Parker Kelley, Gabriel Sturm, Katy Venable et al.
preprint
Serotonergic psychedelics produce therapeutic effects in clinical trials of diverse neuropsychiatric disorders, and preclinical models of inflammatory, cardiometabolic, and neuropsychiatric diseases. These effects appear largely mediated by the serotonin 5-HT2A receptor (5-HT2AR). How could psychedelics elicit transdiagnostic therapeutic effects through a single receptor across tissues as...
Frontiers in Neuroscience
2026
Marcos Lago, Mariana Cerveira, Joe Xavier Simonet
1 citation
Advanced Alzheimer's disease (AD) is generally regarded as a stage of irreversible functional decline. Psilocybin is known to transiently alter large-scale brain network dynamics and to induce plasticity-related mechanisms in preclinical models, yet clinical data in advanced dementia remain lacking. We report the case of an octogenarian Japanese-American woman with a 10-year history of...